Circulating miR-206 and Wnt-signaling are associated with cardiovascular complications and a history of preeclampsia in women. (21st January 2020)

• Record Type: Journal Article
• Authors: Schlosser, Kenny; Kaur, Amanpreet; Dayan, Natalie; Stewart, Duncan J.; Pilote, Louise; Delles, Christian
• Is Part Of: Clinical science. Volume 134:Number 2(2020)
• Page Start: 87
• Page End: 101
• Publication Date: 2020-01-21
• Subjects: acute coronary syndrome -- microRNA -- preeclampsia -- RNA sequencing; Medicine -- Periodicals; Biochemistry -- Periodicals; 616
• DOI: 10.1042/CS20190920
• Languages: English
• ISSNs: 0143-5221

Abstract

Abstract: Women with a history of preeclampsia (PE) have increased risk of cardiovascular disease (CVD) later in life. However, the molecular determinants underlying this risk remain unclear. We sought to understand how circulating miRNA levels are affected by prior PE, and related to biological pathways underpinning cardiovascular disease. RNA sequencing was used to profile plasma levels of 2578 miRNAs in a retrospective study of women with a history of PE or normotensive pregnancy, in two independent cohorts with either acute coronary syndrome (ACS) ( n = 17–18/group) or no ACS ( n = 20/group). Differential miRNA alterations were assessed in relation to a history of PE (within each cohort) or ACS (across cohorts), and compared with miRNAs previously reported to be altered during PE. A history of PE was associated with altered levels of 30 and 20 miRNAs in the ACS and non-ACS cohorts, respectively, whereas ACS exposure was associated with alterations in 259 miRNAs. MiR-206 was identified at the intersection of all comparisons relating to past/current PE and ACS exposure, and has previously been implicated in atherogenic activities related to hepatocytes, vascular smooth muscle cells and macrophages. Integration of all differentially altered miRNAs with their predicted and experimentally validated targets in silico revealed a number of highly targeted genes with potential atherogenic functions (including NFAT5, CCND2 and SMAD2), and one significantly enriched KEGG biological pathway (Wnt signaling) that was shared between all exposure groups. The present study provides novel insights into miRNAs, target genes and biological pathways that may underlie the long-term cardiovascular sequelae of PE.